These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12802916)

  • 1. Correlation between cell size and CD38 expression in chronic lymphocytic leukaemia.
    Manocha S; Matrai Z; Osthoff M; Carter A; Pettitt AR
    Leuk Lymphoma; 2003 May; 44(5):797-800. PubMed ID: 12802916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia.
    Hsi ED; Kopecky KJ; Appelbaum FR; Boldt D; Frey T; Loftus M; Hussein MA
    Br J Haematol; 2003 Mar; 120(6):1017-25. PubMed ID: 12648072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.
    Boonstra JG; von't Veer MB; Gratama JW
    J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of CD38 expression and its quantification in B cell chronic lymphocytic leukemia (B-CLL).
    Mainou-Fowler T; Dignum HM; Proctor SJ; Summerfield GP
    Leuk Lymphoma; 2004 Mar; 45(3):455-62. PubMed ID: 15160906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Dignum H; Taylor PR; Dickinson AM; Saunders PW; Proctor SJ; Summerfield GP
    Br J Haematol; 2002 Sep; 118(3):755-61. PubMed ID: 12181042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
    Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative importance of CD38 expression over myeloid-associated markers expression in predicting the clinical course of B-CLL patients.
    Chang CC; Liu CZ; Cleveland RP
    Leuk Lymphoma; 2003 Jun; 44(6):977-82. PubMed ID: 12854897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.
    Kroft SH; Dawson DB; McKenna RW
    Am J Clin Pathol; 2001 Mar; 115(3):385-95. PubMed ID: 11242795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD38 as a prognostic marker in CLL.
    Matrai Z
    Hematology; 2005 Feb; 10(1):39-46. PubMed ID: 16019444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.
    Dürig J; Naschar M; Schmücker U; Renzing-Köhler K; Hölter T; Hüttmann A; Dührsen U
    Leukemia; 2002 Jan; 16(1):30-5. PubMed ID: 11840260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
    Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
    Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
    Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.
    Zupo S; Isnardi L; Megna M; Massara R; Malavasi F; Dono M; Cosulich E; Ferrarini M
    Blood; 1996 Aug; 88(4):1365-74. PubMed ID: 8695855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL.
    Pittner BT; Jelinek DF; Kay NE
    Leukemia; 2004 Jan; 18(1):180-2. PubMed ID: 14523466
    [No Abstract]   [Full Text] [Related]  

  • 16. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
    Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
    Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of CD38 expression in chronic lymphocytic leukemia.
    Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S
    Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.
    Ghia P; Guida G; Stella S; Gottardi D; Geuna M; Strola G; Scielzo C; Caligaris-Cappio F
    Blood; 2003 Feb; 101(4):1262-9. PubMed ID: 12406914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.